Experiment 398120

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationJANSSENS,D: MICHIELS,C: GUILLAUME,G: CUISINIER,B: LOUAGIE,Y: REMACLE,J:. (1999). INCREASE IN CIRCULATING ENDOTHELIAL CELLS IN PATIENTS WITH PRIMARY CHRONIC VENOUS INSUFFICIENCY: PROTECTIVE EFFECT OF GINKGO FORT IN A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONROLLED CLINICAL TRIAL.. 33(1)
Amount utilized
Compound isolated
DiseaseTHE PROTECTIVE EFFECT OF VENOTROPIC DRUG GINKO FORT, WAS TESTED BY RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL. IN THE ACTIVE-TREATMENT GROUP, THE MEAN VALUES OF THE CEC COUNT DECREASED BY 14.5% AFTER A 4-WEEK TREATMENT, WHEREAS IN THE PLACEBO GROUP, THE DECREASE WAS LESS (8.4%). THE DECREASE FROM WEEK 0 TO THE END OF TREATMENT WAS SIGNIFICANTLY HIGHER IN THE ACTIVE-TREATMENT GROUP THAN IN THE PLACEBO GROUP. THESE RESULTS CONFIRM THE IMPORTANT ROLE OF THE ENDOTHELIUM ALTERATIONS IN THE DEVELOPMENT OF VARICOSE VEINS AND SUGGEST A POTENTIAL BENEFICIAL ACTION OF A VENOTROPIC DRUG ON THE VENOUS WALL.
Dose amount625.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractHYDRO-ALCOHOLIC EXT
GenderFEMALE